PhaseBio Pharmaceuticals, Inc. ( PHAS) - Stock Earnings
Stock symbol PHAS is outdated, potentially delisted? Maybe it is available on other exchange?
PHAS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q4 | -43.1 million USD | 158000 USD |
| 2022Q1 | -11.1 million USD | 117000 USD |
| 2022Q2 | -16.7 million USD | 208000 USD |
PHAS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2019 | -39.2 million USD | 2.4 million USD |
| 2020 | -98.6 million USD | 320000 USD |
| 2021 | -131.1 million USD | 10.8 million USD |
PHAS
Price: $0.07
52 week price:
Earnings Per Share: -2.64 USD
P/E Ratio: -1.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 8.6 million
Market Capitalization: 3.4 million